On Point: Biologics Drive Growth in Pre-Filled Syringes

Launched in 1988, BioPharm International covers all aspects of biopharmaceutical development, analysis, processing, and packaging, as well as business strategies and regulatory issues. The print and digital editorial coverage provides technical and business insight for all biologic-based therapies, reaching professionals involved in the development and manufacturing of biopharmaceutical therapeutics and diagnostics.

An article considering the growth of pre-filled safety syringes as being driven by the rising use and development of biological drugs, Owen Mumford Pharmaceutical Services’ Head of Product Insight and Development, George I’ons, discusses the challenges and safety considerations when developing combination products using pre-filled safety syringes.